Vol.

41

No.

10

March 13, 2015Mar 13, 2015

Free

DOWNLOAD THE PDF

Cover Story

Cancer Centers Join to Accelerate Trials, Industry ollaborations, Drug Development

By Matthew Bin Han Ong

Six NCI-designated cancer centers have agreed to pool data from their electronic medical record systems and cancer registries to accelerate discovery of targets and the development of biomarkers.

Conversation with The Cancer Letter

Dalton: I Don't Know Another Place like ORIEN

By Matthew Bin Han Ong

U.S. Prescription Drug Spending Increased 13 Percent in 2014

Recent Issues

Volume 51 | Issue 33 - September 12, 2025

Scroll to top

Cancer Centers Join to Accelerate Trials, Industry ollaborations, Drug Development

Dalton: I Don't Know Another Place like ORIEN

U.S. Prescription Drug Spending Increased 13 Percent in 2014

In Brief

Nancy Davidson Chosen as President-Elect of AACR; Kim Named Director of FDA's Division of Oncology Products 1

Geoffrey Kim named director of FDA’s Division of Hematology Oncology Products 1

Sagar Lonial and Charles Stately join senior leadership of Winship Cancer Institute

Kevin Behrns named co-editor-and-chief of Surgery

Inderbir Gill appointed chair of global initiatives for the American Urological Association

University of Virginia and Novant Health to form Northern Virginia regional health system

World Molecular Imaging Society and NCI to collaborate on best practices for co-clinical trials

Varian Medical Systems chosen to equip two proton therapy centers in England

Cancer researchers launch mobile app to track breast cancer symptoms

Drugs & Targets

FDA Approves Unituxin for High-Risk Neuroblastoma

Fast Track Designation granted to HS-410 in bladder cancer

Reolysin granted third orphan drug designation

Leukemia and Lymphoma Society published a study on capping cost-sharing for prescription drugs

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login